Neoleukin Therapeutics Provides Update on COVID-19 Impact on Corporate and Clinical Development Activities
SEATTLE, April 09, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc. “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to […]